VivoSim Labs (VIVS) Asset Utilization Ratio (2011 - 2026)
VivoSim Labs (VIVS) posted quarterly Asset Utilization Ratio of 0.02 for Q1 2026, up 17.28% year-over-year from 0.02 in Q1 2025, and up 7.04% quarter-over-quarter from 0.02 in Q4 2025.
VivoSim Labs (VIVS) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
VivoSim Labs' Asset Utilization Ratio history runs 14 years deep, the most recent figure standing at 0.02 for Q1 2026.
- In Q1 2026, Asset Utilization Ratio rose 17.28% year-over-year to 0.02; the TTM figure through Mar 2026 stood at 0.02 (up 17.28% YoY), while the FY2026 annual figure was 0.01, down 13.31% from the prior year.
- Asset Utilization Ratio for Q1 2026 stood at 0.02, up from 0.02 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 0.06 in Q4 2022, with the low at 0.01 in Q2 2024.
- The 5-year median for Asset Utilization Ratio is 0.02 (2026), against an average of 0.03.
- The sharpest annual moves came in 2024 and 2026: Asset Utilization Ratio slumped 72.35% in 2024, then climbed 17.28% in 2026.
- VivoSim Labs' Asset Utilization Ratio stood at 0.06 in 2022, then plunged by 62.54% to 0.02 in 2023, then decreased by 4.66% to 0.02 in 2024, then dropped by 25.9% to 0.02 in 2025, then increased by 7.04% to 0.02 in 2026.
- Business Quant data shows VIVS's Asset Utilization Ratio at 0.02 in Q1 2026, 0.02 in Q4 2025, and 0.01 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 0.90 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.13 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.54 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.13 |
| 10 | VivoSim Labs | 1.49 Mn | 1.49 Mn | - | 0.02 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.02 |
| Mar 31, 2026 | 0.02 |
| Dec 31, 2025 | 0.02 |
| Sep 30, 2025 | 0.01 |
| Jun 30, 2025 | 0.01 |
| Mar 31, 2025 | 0.02 |
| Dec 31, 2024 | 0.02 |
| Sep 30, 2024 | 0.01 |
| Jun 30, 2024 | 0.01 |
| Mar 31, 2024 | 0.01 |
| Dec 31, 2023 | 0.02 |
| Sep 30, 2023 | 0.04 |
| Jun 30, 2023 | 0.03 |
| Mar 31, 2023 | 0.02 |
| Dec 31, 2022 | 0.06 |
| Sep 30, 2022 | 0.05 |
| Jun 30, 2022 | 0.05 |
| Mar 31, 2022 | 0.04 |
| Sep 30, 2020 | 0.01 |
| Jun 30, 2020 | 0.06 |